HomeOmeprazoleOmeprazole + Tocilizumab Aazg

Does Omeprazole Interact with Tocilizumab Aazg?

Omeprazole and Tocilizumab Aazg have a moderate drug interaction according to U.S. FDA drug labeling data. Tocilizumab may decrease omeprazole exposure by up to 28%; monitor effect and adjust dose as needed. The mechanism involves restoration of cyp2c19 and cyp3a4 activity by il-6 inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Omeprazole Class
Proton Pump Inhibitor
Tocilizumab Aazg Class
Interleukin-6 Receptor Antagonist
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Omeprazole and Tocilizumab Aazg occurs because restoration of cyp2c19 and cyp3a4 activity by il-6 inhibition. Clinically, this means tocilizumab may decrease omeprazole exposure by up to 28%; monitor effect and adjust dose as needed. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Omeprazole and your doctor is considering prescribing Tocilizumab Aazg (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Omeprazole+💊 Tocilizumab Aazg(Tyenne)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Proton Pump Inhibitor
Drug B class
Interleukin-6 Receptor Antagonist
Source
NLP:tocilizumab-aazg

What this means in plain English

Tocilizumab may decrease omeprazole exposure by up to 28%; monitor effect and adjust dose as needed.

What the FDA label says

"Restoration of CYP2C19 and CYP3A4 activity by IL-6 inhibition"

📖 Source: NLP:tocilizumab-aazg

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Omeprazole and Tocilizumab Aazg against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.